Recognition of this linkage prompted us to conduct a genomic profiling of LS patients aimed at identifying IGF1-dependent genes and signaling pathways that are differentially expressed in LS and that may shed information on the molecular foundation for cancer evasion in this condition. The gene discussed is IGF1; the disease is cancer.